Schroeder, C., Navid-Hill, E., Meiners, J., Hube-Magg, C., Kluth, M., Makrypidi-Fraune, G., . . . Höflmayer, D. (2019). Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget.
シカゴスタイル引用形Schroeder, Cornelia, et al. "Nuclear ELAC2 Overexpression Is Associated With Increased Hazard for Relapse After Radical Prostatectomy." Oncotarget 2019.
MLA引用形式Schroeder, Cornelia, et al. "Nuclear ELAC2 Overexpression Is Associated With Increased Hazard for Relapse After Radical Prostatectomy." Oncotarget 2019.
警告: この引用は必ずしも正確ではありません.